{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:51:57Z","timestamp":1792644717508,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T00:00:00Z","timestamp":1508198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T00:00:00Z","timestamp":1508198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Many high-grade serous carcinomas (HGSCs) of the pelvis are thought to originate in the distal portion of the fallopian tube. Serous tubal intra-epithelial carcinoma (STIC) lesions are the putative precursor to HGSC and identifiable in ~\u200950% of advanced stage cases. To better understand the molecular etiology of HGSCs, we report a multi-center integrated genomic analysis of advanced stage tumors with and without STIC lesions and normal tissues. The most significant focal DNA SCNAs were shared between cases with and without STIC lesions. The RNA sequence and the miRNA data did not identify any clear separation between cases with and without STIC lesions. HGSCs had molecular profiles more similar to normal fallopian tube epithelium than ovarian surface epithelium or peritoneum. The data suggest that the molecular features of HGSCs with and without associated STIC lesions are mostly shared, indicating a common biologic origin, likely to be the distal fallopian tube among all cases.<\/jats:p>","DOI":"10.1038\/s41467-017-01217-9","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T15:29:31Z","timestamp":1507735771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":212,"title":["Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma"],"prefix":"10.1038","volume":"8","author":[{"given":"Jennifer","family":"Ducie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Dao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Considine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narciso","family":"Olvera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Kurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ie-Ming","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Soslow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Cope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1038-8232","authenticated-orcid":false,"given":"Douglas A.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,17]]},"reference":[{"key":"1217_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","volume":"186","author":"RJ Kurman","year":"2016","unstructured":"Kurman, R. J. & Shih, Ie. M. The dualistic model of ovarian carcinogenesis: Revisited, revised, and expanded. Am. J. Pathol. 186, 733\u2013747 (2016).","journal-title":"Am. J. Pathol."},{"key":"1217_CR2","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1158\/2159-8290.CD-16-0607","volume":"6","author":"MA Eckert","year":"2016","unstructured":"Eckert, M. A. et al. Genomics of ovarian cancer progression reveals diverse metastatic trajectories including intraepithelial metastasis to the fallopian tube. Cancer Discov. 6, 1342\u20131351 (2016).","journal-title":"Cancer Discov."},{"key":"1217_CR3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/path.3023","volume":"226","author":"E Kuhn","year":"2012","unstructured":"Kuhn, E. et al. TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions. J. Pathol. 226, 421\u2013426 (2012).","journal-title":"J. Pathol."},{"key":"1217_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","volume":"31","author":"DW Kindelberger","year":"2007","unstructured":"Kindelberger, D. W. et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am. J. Surg. Pathol. 31, 161\u2013169 (2007).","journal-title":"Am. J. Surg. Pathol."},{"key":"1217_CR5","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ygyno.2008.05.010","volume":"110","author":"S Salvador","year":"2008","unstructured":"Salvador, S. et al. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma. Gynecol. Oncol. 110, 408\u2013417 (2008).","journal-title":"Gynecol. Oncol."},{"key":"1217_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrc.2016.113","volume":"17","author":"AN Karnezis","year":"2017","unstructured":"Karnezis, A. N., Cho, K. R., Gilks, C. B., Pearce, C. L. & Huntsman, D. G. The disparate origins of ovarian cancers: pathogenesis and prevention strategies. Nat. Rev. Cancer 17, 65\u201374 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"1217_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1158\/0008-5472.CAN-15-1382","volume":"76","author":"R Perets","year":"2016","unstructured":"Perets, R. & Drapkin, R. It\u2019s totally tubular\u2026.riding the new wave of ovarian cancer research. Cancer Res. 76, 10\u201317 (2016).","journal-title":"Cancer Res."},{"issue":"Suppl 8","key":"1217_CR8","doi-asserted-by":"publisher","first-page":"viii28","DOI":"10.1093\/annonc\/mdt308","volume":"24","author":"L Dubeau","year":"2013","unstructured":"Dubeau, L. & Drapkin, R. Coming into focus: the nonovarian origins of ovarian cancer. Ann. Oncol. 24(Suppl 8), viii28\u2013viii35 (2013).","journal-title":"Ann. Oncol."},{"key":"1217_CR9","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/PAS.0b013e3181dcede7","volume":"34","author":"E Kuhn","year":"2010","unstructured":"Kuhn, E. et al. Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis. Am. J. Surg. Pathol. 34, 829\u2013836 (2010).","journal-title":"Am. J. Surg. Pathol."},{"key":"1217_CR10","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.1158\/0008-5472.CAN-07-6595","volume":"68","author":"T Bonome","year":"2008","unstructured":"Bonome, T. et al. A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer. Cancer Res. 68, 5478\u20135486 (2008).","journal-title":"Cancer Res."},{"key":"1217_CR11","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1200\/JCO.2006.06.3743","volume":"25","author":"HK Dressman","year":"2007","unstructured":"Dressman, H. K. et al. An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer. J. Clin. Oncol. 25, 517\u2013525 (2007).","journal-title":"J. Clin. Oncol."},{"key":"1217_CR12","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","volume":"14","author":"RW Tothill","year":"2008","unstructured":"Tothill, R. W. et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin. Cancer Res. 14, 5198\u20135208 (2008).","journal-title":"Clin. Cancer Res."},{"key":"1217_CR13","first-page":"517","volume":"123","author":"RG Verhaak","year":"2013","unstructured":"Verhaak, R. G. et al. Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. J. Clin. Invest. 123, 517\u2013525 (2013).","journal-title":"J. Clin. Invest."},{"key":"1217_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research N","year":"2011","unstructured":"Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609\u2013615 (2011).","journal-title":"Nature"},{"issue":"Suppl 2","key":"1217_CR15","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1038\/modpathol.3800306","volume":"18","author":"DA Bell","year":"2005","unstructured":"Bell, D. A. Origins and molecular pathology of ovarian cancer. Mod. Pathol. 18(Suppl 2), S19\u2013S32 (2005).","journal-title":"Mod. Pathol."},{"key":"1217_CR16","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L","volume":"73","author":"DA Bell","year":"1994","unstructured":"Bell, D. A. & Scully, R. E. Early de novo ovarian carcinoma. A study of fourteen cases. Cancer 73, 1859\u20131864 (1994).","journal-title":"Cancer"},{"key":"1217_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ygyno.2009.03.023","volume":"114","author":"KQ Cai","year":"2009","unstructured":"Cai, K. Q., Wu, H., Klein-Szanto, A. J. & Xu, X. X. Acquisition of a second mutation of the Tp53 alleles immediately precedes epithelial morphological transformation in ovarian tumorigenicity. Gynecol. Oncol. 114, 18\u201325 (2009).","journal-title":"Gynecol. Oncol."},{"key":"1217_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0046-8177(99)90269-1","volume":"30","author":"BA Werness","year":"1999","unstructured":"Werness, B. A. et al. Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer. Hum. Pathol. 30, 151\u2013157 (1999).","journal-title":"Hum. Pathol."},{"key":"1217_CR19","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","volume":"34","author":"CG Przybycin","year":"2010","unstructured":"Przybycin, C. G., Kurman, R. J., Ronnett, B. M., Shih Ie, M. & Vang, R. Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am. J. Surg. Pathol. 34, 1407\u20131416 (2010).","journal-title":"Am. J. Surg. Pathol."},{"key":"1217_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/126295","volume":"2010","author":"AL Gross","year":"2010","unstructured":"Gross, A. L., Kurman, R. J., Vang, R., Shih Ie, M. & Visvanathan, K. Precursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristics. J. Oncol. 2010, 126295 (2010).","journal-title":"J. Oncol."},{"key":"1217_CR21","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/modpathol.2014.89","volume":"28","author":"MH Chui","year":"2015","unstructured":"Chui, M. H. et al. Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma. Mod. Pathol. 28, 437\u2013445 (2015).","journal-title":"Mod. Pathol."},{"key":"1217_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/path.4147","volume":"229","author":"JJ Sheu","year":"2013","unstructured":"Sheu, J. J. et al. Rsf-1, a chromatin remodelling protein, interacts with cyclin E1 and promotes tumour development. J. Pathol. 229, 559\u2013568 (2013).","journal-title":"J. Pathol."},{"key":"1217_CR23","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1038\/modpathol.2016.101","volume":"29","author":"E Kuhn","year":"2016","unstructured":"Kuhn, E. et al. CCNE1 amplification and centrosome number abnormality in serous tubal intraepithelial carcinoma: further evidence supporting its role as a precursor of ovarian high-grade serous carcinoma. Mod. Pathol. 29, 1254\u20131261 (2016).","journal-title":"Mod. Pathol."},{"key":"1217_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/path.4353","volume":"233","author":"CA Sherman-Baust","year":"2014","unstructured":"Sherman-Baust, C. A. et al. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development. J. Pathol. 233, 228\u2013237 (2014).","journal-title":"J. Pathol."},{"key":"1217_CR25","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","volume":"24","author":"R Perets","year":"2013","unstructured":"Perets, R. et al. Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models. Cancer Cell. 24, 751\u2013765 (2013).","journal-title":"Cancer Cell."},{"key":"1217_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-pathol-020712-163949","volume":"9","author":"NN Nik","year":"2014","unstructured":"Nik, N. N., Vang, R., Shih Ie, M. & Kurman, R. J. Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma. Annu. Rev. Pathol. 9, 27\u201345 (2014).","journal-title":"Annu. Rev. Pathol."},{"key":"1217_CR27","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.1073\/pnas.1117135109","volume":"109","author":"J Kim","year":"2012","unstructured":"Kim, J. et al. High-grade serous ovarian cancer arises from fallopian tube in a mouse model. Proc. Natl Acad. Sci. USA 109, 3921\u20133926 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1217_CR28","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","volume":"42","author":"RJ Kurman","year":"2011","unstructured":"Kurman, R. J. & Shih, Ie. M. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm. Hum. Pathol. 42, 918\u2013931 (2011).","journal-title":"Hum. Pathol."},{"key":"1217_CR29","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/onc.2009.402","volume":"29","author":"K Levanon","year":"2010","unstructured":"Levanon, K. et al. Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis. Oncogene 29, 1103\u20131113 (2010).","journal-title":"Oncogene"},{"key":"1217_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/path.2091","volume":"211","author":"Y Lee","year":"2007","unstructured":"Lee, Y. et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J. Pathol. 211, 26\u201335 (2007).","journal-title":"J. Pathol."},{"key":"1217_CR31","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1001\/jamaoncol.2015.1618","volume":"1","author":"AS McDaniel","year":"2015","unstructured":"McDaniel, A. S. et al. Next-generation sequencing of tubal intraepithelial carcinomas. JAMA Oncol. 1, 1128\u20131132 (2015).","journal-title":"JAMA Oncol."},{"key":"1217_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010358","volume":"5","author":"B Pothuri","year":"2010","unstructured":"Pothuri, B. et al. Genetic analysis of the early natural history of epithelial ovarian carcinoma. PLoS ONE 5, e10358 (2010).","journal-title":"PLoS ONE"},{"key":"1217_CR33","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1210\/en.2014-1977","volume":"156","author":"J Kim","year":"2015","unstructured":"Kim, J., Coffey, D. M., Ma, L. & Matzuk, M. M. The ovary is an alternative site of origin for high-grade serous ovarian cancer in mice. Endocrinology 156, 1975\u20131981 (2015).","journal-title":"Endocrinology"},{"key":"1217_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju146","volume":"106","author":"B Guan","year":"2014","unstructured":"Guan, B. et al. Roles of deletion of Arid1a, a tumor suppressor, in mouse ovarian tumorigenesis. J. Natl. Cancer Inst. 106, dju146 (2014).","journal-title":"J. Natl. Cancer Inst."},{"key":"1217_CR35","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jamcollsurg.2011.12.028","volume":"214","author":"EA Levine","year":"2012","unstructured":"Levine, E. A. et al. Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes. J. Am. Coll. Surg. 214, 599\u2013606 (2012).","journal-title":"J. Am. Coll. Surg."},{"key":"1217_CR36","doi-asserted-by":"publisher","first-page":"6422","DOI":"10.1158\/1078-0432.CCR-05-0508","volume":"11","author":"KK Zorn","year":"2005","unstructured":"Zorn, K. K. et al. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Clin. Cancer Res. 11, 6422\u20136430 (2005).","journal-title":"Clin. Cancer Res."},{"key":"1217_CR37","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","volume":"163","author":"G Ciriello","year":"2015","unstructured":"Ciriello, G. et al. Comprehensive molecular portraits of invasive lobular breast cancer. Cell 163, 506\u2013519 (2015).","journal-title":"Cell"},{"key":"1217_CR38","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1101\/gad.263145.115","volume":"29","author":"EA Semenova","year":"2015","unstructured":"Semenova, E. A., Nagel, R. & Berns, A. Origins, genetic landscape, and emerging therapies of small cell lung cancer. Genes Dev. 29, 1447\u20131462 (2015).","journal-title":"Genes Dev."},{"key":"1217_CR39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.molonc.2010.05.002","volume":"4","author":"KD Sutherland","year":"2010","unstructured":"Sutherland, K. D. & Berns, A. Cell of origin of lung cancer. Mol. Oncol. 4, 397\u2013403 (2010).","journal-title":"Mol. Oncol."},{"key":"1217_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju249","volume":"106","author":"GE Konecny","year":"2014","unstructured":"Konecny, G. E. et al. Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer. J. Natl Cancer Inst. 106, pii:dju249 (2014).","journal-title":"J. Natl Cancer Inst."},{"key":"1217_CR41","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","volume":"34","author":"AR Laury","year":"2010","unstructured":"Laury, A. R. et al. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. Am. J. Surg. Pathol. 34, 627\u2013635 (2010).","journal-title":"Am. J. Surg. Pathol."},{"key":"1217_CR42","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/AOG.0000000000000484","volume":"124","author":"BK Erickson","year":"2014","unstructured":"Erickson, B. K. et al. Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancer. Obstet. Gynecol. 124, 881\u2013885 (2014).","journal-title":"Obstet. Gynecol."},{"key":"1217_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004952","volume":"5","author":"I Kinde","year":"2013","unstructured":"Kinde, I. et al. Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers. Sci. Transl. Med. 5, 167ra164 (2013).","journal-title":"Sci. Transl. Med."},{"key":"1217_CR44","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/PGP.0b013e31823b8831","volume":"31","author":"R Vang","year":"2012","unstructured":"Vang, R. et al. Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma. Int. J. Gynecol. Pathol. 31, 243\u2013253 (2012).","journal-title":"Int. J. Gynecol. Pathol."},{"key":"1217_CR45","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1097\/PAS.0b013e31822f58bc","volume":"35","author":"K Visvanathan","year":"2011","unstructured":"Visvanathan, K. et al. Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study. Am. J. Surg. Pathol. 35, 1766\u20131775 (2011).","journal-title":"Am. J. Surg. Pathol."},{"key":"1217_CR46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nature07517","volume":"456","author":"DR Bentley","year":"2008","unstructured":"Bentley, D. R. et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456, 53\u201359 (2008).","journal-title":"Nature"},{"key":"1217_CR47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"1217_CR48","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"1217_CR49","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1093\/bioinformatics\/bts356","volume":"28","author":"L Wang","year":"2012","unstructured":"Wang, L., Wang, S. & Li, W. RSeQC: quality control of RNA-seq experiments. Bioinformatics 28, 2184\u20132185 (2012).","journal-title":"Bioinformatics"},{"key":"1217_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).","journal-title":"Genome Biol."},{"key":"1217_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman, R. C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004).","journal-title":"Genome Biol."},{"key":"1217_CR52","doi-asserted-by":"publisher","DOI":"10.2202\/1544-6115.1027","volume":"3","author":"GK Smyth","year":"2004","unstructured":"Smyth G. K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, 3 (2004)","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"key":"1217_CR53","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1093\/bioinformatics\/bts188","volume":"28","author":"D Waggott","year":"2012","unstructured":"Waggott, D. et al. NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA data. Bioinformatics 28, 1546\u20131548 (2012).","journal-title":"Bioinformatics"},{"key":"1217_CR54","doi-asserted-by":"publisher","first-page":"W498","DOI":"10.1093\/nar\/gks494","volume":"40","author":"IS Vlachos","year":"2012","unstructured":"Vlachos, I. S. et al. DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res. 40, W498\u2013W504 (2012).","journal-title":"Nucleic Acids Res."},{"key":"1217_CR55","unstructured":"Affymetrix. https:\/\/www.thermofisher.com\/us\/en\/home\/life-science\/microarray-analysis\/microarray-analysis-partners-programs\/affymetrix-developers-network\/affymetrix-power-tools.html (2017)."},{"key":"1217_CR56","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/biostatistics\/kxh008","volume":"5","author":"AB Olshen","year":"2004","unstructured":"Olshen, A. B., Venkatraman, E. S., Lucito, R. & Wigler, M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5, 557\u2013572 (2004).","journal-title":"Biostatistics"},{"key":"1217_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).","journal-title":"Genome Biol."},{"key":"1217_CR58","unstructured":"Team R. C. R: A language and environment for statistical computing. http:\/\/www.r-project.org\/ (2014)."},{"key":"1217_CR59","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01217-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01217-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01217-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T13:48:45Z","timestamp":1719496125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01217-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,17]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1217"],"URL":"https:\/\/doi.org\/10.1038\/s41467-017-01217-9","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732005944.793539321","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,17]]},"assertion":[{"value":"9 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"990"}}